- Joined
- 3 May 2009
- Posts
- 515
- Reactions
- 2
Some pretty serious volumes going through again today.
Price took a hit but VWAP was 20.4 cents.
Given that nasdaq listing approval was supposed to take 90 days at the outside as posted on 30/09/10 it must be getting very close now.
Looking at these volumes I'm thinking some big boys are loading up to onsell to Bank Of New York Mellon as ADR's when PRR lists.
Now the JP Morgan conference is the biggest in the world for biotech where PRR is presenting next week.
So potentially we have a gigantic new tech savvy investor base that could be clamouring for a piece of the action via the ADRs which are going to trade at 30 to 1.
Say initial interest in the US is 10 million shares on the Nasdaq =300 million less on the ASX.
The past four days trading have seen about 100 million change hands. Someone is loading up.
IMHO once the Nasdaq listing is confirmed (presumably there are no logical impediments to this happenstance) ASX holders are probably going to be less likely to release their shares to Mellon and there is going to be a huge liquidity squeeze.
The timelines for Cvac are drawing closer to registration and sales as well. And the really long term thought is how Cvac will perform clinically against breast cancer.
I'm weighted in now for my SMSF and will be following with interest.
Price took a hit but VWAP was 20.4 cents.
Given that nasdaq listing approval was supposed to take 90 days at the outside as posted on 30/09/10 it must be getting very close now.
Looking at these volumes I'm thinking some big boys are loading up to onsell to Bank Of New York Mellon as ADR's when PRR lists.
Now the JP Morgan conference is the biggest in the world for biotech where PRR is presenting next week.
So potentially we have a gigantic new tech savvy investor base that could be clamouring for a piece of the action via the ADRs which are going to trade at 30 to 1.
Say initial interest in the US is 10 million shares on the Nasdaq =300 million less on the ASX.
The past four days trading have seen about 100 million change hands. Someone is loading up.
IMHO once the Nasdaq listing is confirmed (presumably there are no logical impediments to this happenstance) ASX holders are probably going to be less likely to release their shares to Mellon and there is going to be a huge liquidity squeeze.
The timelines for Cvac are drawing closer to registration and sales as well. And the really long term thought is how Cvac will perform clinically against breast cancer.
I'm weighted in now for my SMSF and will be following with interest.